Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-16-121537
Filing Date
2016-08-26
Accepted
2016-08-26 17:18:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 v447756_424b5.htm 424B5 433380
2 GRAPHIC image_001.jpg GRAPHIC 79176
3 GRAPHIC tpg9.jpg GRAPHIC 100321
  Complete submission text file 0001144204-16-121537.txt   682100
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-205128 | Film No.: 161855552
SIC: 2834 Pharmaceutical Preparations